Applied Therapeutics is a clinical-stage biopharmaceutical company that creates innovative products to target cardiovascular disease, galactosemia, and diabetic complications. They have multiple product candidates in various clinical stages, including phase III clinical trials for diabetic cardiomyopathy. Established in 2016, the company is based in New York City.